Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amaranthus spinosus pollen extract
- Development stage
- Unknown
- Lead developer
- ALK Abelló
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intradermal, Percutaneous
01
Overview
Amaranthus spinosus pollen extract is a biologic allergen extract derived from the pollen of the spiny amaranth weed. It is a prescription drug used for both the diagnosis and treatment of Type I hypersensitivity disorders, such as allergic rhinitis and seasonal asthma. For diagnosis, it is used in allergy skin tests to identify sensitization. For treatment, it is administered as immunotherapy (hyposensitization) via injection to desensitize patients by gradually exposing their immune system to the allergen. This process aims to reduce the IgE-mediated allergic response. The extract contains multiple allergenic protein fractions and is manufactured by Allergy Laboratories, Inc.
- Brand names
- Pigweed Mix, Rough/spiny Pollen
- Other names
- Spiny Pigweed Pollen
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on amaranthus spinosus pollen extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on amaranthus spinosus pollen extract.